These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21147290)

  • 1. Antiplatelet and antithrombotic treatment after primary percutaneous coronary intervention: balancing safety and efficacy.
    Valgimigli M; Minarelli M
    Am Heart J; 2010 Dec; 160(6 Suppl):S36-41. PubMed ID: 21147290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.
    Lopes RD; Li L; Granger CB; Wang TY; Foody JM; Funk M; Peterson ED; Alexander KP
    Am J Med; 2012 Sep; 125(9):897-905. PubMed ID: 22795814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prasugrel: an efficacy and safety review of a new antiplatelet therapy option.
    Armani AM
    Crit Pathw Cardiol; 2010 Dec; 9(4):199-202. PubMed ID: 21119337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
    Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
    J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
    Wallén H; Agren A; Nekludov M
    Lakartidningen; 2007 Nov 28-Dec 4; 104(48):3640-2. PubMed ID: 18193674
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges in oral antiplatelet therapy: ST-segment elevation myocardial infarction.
    Dauerman HL
    Am J Cardiol; 2009 Sep; 104(5 Suppl):39C-43C. PubMed ID: 19695360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of bleeding and time dependence of association of bleeding with mortality: insights from the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel--Thrombolysis in Myocardial Infarction 38 (TRITON-TIMI 38).
    Hochholzer W; Wiviott SD; Antman EM; Contant CF; Guo J; Giugliano RP; Dalby AJ; Montalescot G; Braunwald E
    Circulation; 2011 Jun; 123(23):2681-9. PubMed ID: 21606391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy.
    Danchin N; Aïssaoui N
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):325-30. PubMed ID: 20714797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?
    Hermosillo AJ; Spinler SA
    Ann Pharmacother; 2008 Jun; 42(6):790-805. PubMed ID: 18477734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused 2012 update of the Canadian Cardiovascular Society guidelines for the use of antiplatelet therapy.
    Tanguay JF; Bell AD; Ackman ML; Bauer RD; Cartier R; Chan WS; Douketis J; Roussin A; Schnell G; Verma S; Wong G; Mehta SR;
    Can J Cardiol; 2013 Nov; 29(11):1334-45. PubMed ID: 23978596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prasugrel: Clinical development and therapeutic application.
    Guerra DR; Tcheng JE
    Adv Ther; 2009 Nov; 26(11):999-1011. PubMed ID: 20020231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of triple antithrombotic therapy after percutaneous coronary intervention in patients needing long-term anticoagulation.
    Singh PP; Singh M; Bedi U; Molnar J; Arora R; Khosla S
    Ther Adv Cardiovasc Dis; 2011 Feb; 5(1):23-31. PubMed ID: 21183532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38).
    Wiviott SD; Antman EM; Gibson CM; Montalescot G; Riesmeyer J; Weerakkody G; Winters KJ; Warmke JW; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):627-35. PubMed ID: 16996826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and use of antiplatelet and antithrombotic drugs during cardiovascular interventions: May 2010 update.
    Cuisset T; Valgimigli M; Mudra H; Muller O; Wijns W; Huber K
    EuroIntervention; 2010 May; 6(1):39-45. PubMed ID: 20542796
    [No Abstract]   [Full Text] [Related]  

  • 17. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 18. Indications for dual antiplatelet therapy with aspirin and clopidogrel: evidence-based recommendations for use.
    Reaume KT; Regal RE; Dorsch MP
    Ann Pharmacother; 2008 Apr; 42(4):550-7. PubMed ID: 18319394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation.
    Gao F; Zhou YJ; Wang ZJ; Yang SW; Nie B; Liu XL; Jia de A; Yan ZX
    Int J Cardiol; 2011 Apr; 148(1):96-101. PubMed ID: 21185095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.